πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10597382

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use th

Enanta Pharmaceuticals, Inc. Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10590121

Kinase inhibitors and methods for making and using

Rigel Pharmaceuticals, Inc. Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10590090

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allost

Revolution Medicines, Inc. Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10588897

Piericidin bacterial inhibitors

The Regents of the University of California Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10590074

Potent and selective inhibitors of monoamine transporters; method of making; and use there

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10590082

N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of gluco

ACADEMISCH MEDISCH CENTRUM Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10584132

SHMT inhibitors

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10584105

Immunoproteasome inhibitor analogs

The Regents of the University of California Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10584115

Substituted pyridine and pyrazine BMI-1 inhibitors

PTC THERAPEUTICS, INC. Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10577349

Quinolinones as inhibitors of translation initiation complex

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10576107

Methods of treating joint diseases, disorders, and conditions with tissue inhibitors of ma

Prime Merger Sub, LLC Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10576145

CD200 inhibitors and methods of use thereof

Regents of the University of Minnesota Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10568888

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570140

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570120

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570153

Benzodiazepine derivatives as RSV inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562850

Human plasma kallikrein inhibitors

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562894

Pyrimidine compound as JAK kinase inhibitor

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10556897

Protein kinase inhibitors

Princeton Drug Discovery, Inc Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10556892

Piperazinyl methanone NAAA inhibitors

The Regents of the University of California Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548889

Compositions of CXCR4 inhibitors and methods of preparation and use

X4 Pharmaceuticals, Inc. Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10550118

JAK inhibitors containing a 4-membered heterocyclic amide

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548883

Benzotriazole-derived Ξ± and Ξ²-unsaturated amide compound used as TGF-Ξ² RI inhibitor

Medshine Discovery Inc. Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548886

Methods of treatment using a JAK inhibitor compound

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted